Background Stillbirths and associated outcomes remain a significant concern in sub-Saharan Africa (SSA), with approximately 41% of global stillbirths. Design Our cross-sectional analysis included a ...

Introduction Postoperative nausea and vomiting (PONV) is a common complication following various surgical procedures, ...

Background Type 2 diabetes is a growing public health concern, and it continues to disproportionately impact priority populations. Although earlier and more frequent screening of diabetes promotes ...

Objective We aimed to estimate prevalence and identify determinants of hypertension in adults aged 15–49 years in Tanzania.

Objective To explore the association between biological rhythm and internalising disorders among children and adolescents. Design, setting and participants This cross-sectional study used data from ...

Objectives This study aimed to explore the relationship between oral health and the knowledge, attitudes and practices (KAP) of parents and teachers of kindergarten students towards oral health.

Introduction In patients with chronic obstructive pulmonary disease (COPD), the risk of certain cardiovascular (CV) events is increased by threefold to fivefold in the year following acute ...

Objective To assess the association between educational level and cardiovascular age acceleration metric derived from ECG, and to determine whether this association is mediated by established ...

Objectives To investigate the change in anticholinergic burden over a 5 year period in relation to the health characteristics of older adults. Study design Using data from the MultiCare Cohort Study ...

Objectives To investigate staff experiences of, and approaches to behaviour that challenges displayed by patients with dementia in the emergency department (ED). Behaviour that challenges is defined ...

Purpose The childhood hand, foot and mouth disease (HFMD) sequelae cohort study (HNHFMDCS) is an ambispective cohort study of patients with HFMD based in Henan Province, China, consisting of patients ...

Objectives Penpulimab is a novel programmed death-1 (PD-1) inhibitor that has been approved in China for use in combination with chemotherapy as a first-line treatment for locally advanced or ...